{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:00:35Z","timestamp":1790834435805,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Nucleic acid amplification Testing (NAT) is expected to minimize the potential risk of transfusion transmitted infections (TTIs) which escaped the detection by serologic screening. Therefore, the aim was to assess the seroprevalence of TTIs (HCV, HBV and HIV) in voluntary blood donors and to verify the accuracy of chemiluminescence (CLIA) test versus NAT as confirmatory test for more safe blood donations in two main university (Mansoura and Assiut) blood transfusion centers in Egypt. A retrospective analysis was done for 87,620 specimens from healthy voluntary blood donors by NAT and CLIA techniques in Mansoura (12,464) and Assiut (75,156) blood transfusion centers. The prevalence of viral reactivity by CLIA was 2.49% (0.77%, 1.69% and 0.03% for HBV, HCV and HIV respectively) and by NAT was 2.25% (HBV 0.71%, HCV 1.52% and HIV 0.02%). The CLIA seroreactivity for HBV was found in 676 samples versus 621 by NAT (589 true positive, 87 false positive and 32 false negative). HCV reactivity was detected in 1477 by CLIA versus 1328 by NAT (1305 true positive, 172 false positive and 23 false negative). HIV results showed (CLIA\/NAT) 22 versus 19 reactive samples (19 true positive, 3 false positive and 0.0 false negative). Comparison of CLIA and NAT results as regards the accuracy revealed 99.86% ,99.78%, and 100% for HBV, HCV, and HIV respectively. The CLIA and NAT techniques showed perfect agreement for detection of HCV (kappa\u2009=\u20090.929), HBV detection (kappa\u2009=\u20090.907) and HIV detection (kappa\u2009=\u20090.900). NAT implementation with CLIA increased blood transfusion safety with the advantage of direct sequence specific detection of virus genome. Therefore, it is a critical role to adopt NAT technology in all blood transfusion centers in Egypt.<\/jats:p>","DOI":"10.1038\/s41598-025-03506-6","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T08:55:18Z","timestamp":1750409718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A comparative analysis between NAT and chemiluminescence in detection of transfusion transmitted viruses in two main university blood transfusion centers"],"prefix":"10.1038","volume":"15","author":[{"given":"Doaa","family":"Shahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayada","family":"Ghannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Sadeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elzeiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-0983","authenticated-orcid":false,"given":"Youssef","family":"Mosaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"abdelhameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"NasrEldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"3506_CR1","doi-asserted-by":"publisher","unstructured":"Biadgo, B., Shiferaw, E., Woldu, B., Alene, K. A. & Melku, M. Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: a three-year retrospective study. PLoS ONE. 7;12: e0180416 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0180416. PMID: 28678865; PMCID: PMC5498040.","DOI":"10.1371\/journal.pone.0180416"},{"key":"3506_CR2","doi-asserted-by":"publisher","first-page":"e0157615","DOI":"10.1371\/journal.pone.0157615","volume":"11","author":"F Farshadpour","year":"2016","unstructured":"Farshadpour, F. et al. Prevalence and trends of transfusion-transmissible viral infections among blood donors in South of Iran: an eleven-year retrospective study. PLoS ONE. 11, e0157615. https:\/\/doi.org\/10.1371\/journal.pone.0157615 (2016). PMID: 27309959; PMCID: PMC4911153.","journal-title":"PLoS ONE"},{"key":"3506_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7243\/2052-434X-2-4","volume":"2","author":"HI Nwokeukwu","year":"2014","unstructured":"Nwokeukwu, H. I., Nwabuko, C. O., Chuku, A., Ajuogu, E. & Dorathy, O. A. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis in blood donors in a tertiary health facility in southeastern Nigeria. Hematol. Leuk. 2, 4. https:\/\/doi.org\/10.7243\/2052-434X-2-4 (2014).","journal-title":"Hematol. Leuk."},{"key":"3506_CR4","unstructured":"Global status report on blood safety and availability 2021. Geneva: World Health Organization; World Health Organization Department of Health Products Policy and Standards 20 avenue Appia CH-1211 Geneva 27 https:\/\/www.who.int\/bloodproducts 9789240051683-eng.pdf (who.int). Last accessed August 2024."},{"key":"3506_CR5","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections. World Health Organization Department of Health Products Policy and Standards 20 avenue Appia CH-1211 Geneva 27 (2021). https:\/\/www.who.int\/bloodproducts 9789240051683-eng.pdf (who.int). Last accessed August 2024."},{"key":"3506_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/voxs.12597","volume":"15","author":"L Roman","year":"2020","unstructured":"Roman, L., Armstrong, B. & Smart, E. Donation testing and transfusion transmissible infections. ISBT Sci. Ser. 15, 192\u2013206. https:\/\/doi.org\/10.3390\/pathogens10121633https:\/\/doi.org\/10.3390\/pathogens10121633 (2020).","journal-title":"ISBT Sci. Ser."},{"issue":"1","key":"3506_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.46701\/BG.2023012022032","volume":"7","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. A chemiluminescence based approach to nucleic acid testing to detect HBV, HCV, and HIV-1 in blood screening[J]. Blood&Genomics 7 (1), 34\u201342. https:\/\/doi.org\/10.46701\/BG.2023012022032 (2023).","journal-title":"Blood&Genomics"},{"issue":"Suppl 5","key":"3506_CR8","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.htct.2024.04.120","volume":"46","author":"M Gadji","year":"2024","unstructured":"Gadji, M. et al. Improvement of blood transfusion safety using the chemiluminescence technique for viral marker screening of blood donors in sub\u2013Saharan Africa. Hematol. Transfus. Cell. Ther. 46 (Suppl 5), S72\u2013S79. https:\/\/doi.org\/10.1016\/j.htct.2024.04.120 (2024). Epub 2024 Sep 7. PMID: 39317575.","journal-title":"Hematol. Transfus. Cell. Ther."},{"issue":"4","key":"3506_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21931\/RB\/2023.08.04.33","volume":"8","author":"S Cadena-Ullauri","year":"2023","unstructured":"Cadena-Ullauri, S. et al. Nucleic acid amplification testing (NAT) impact on blood safety compared to immunoassays in blood banks: A review. Revis. Bionatura. 8 (4), 31. https:\/\/doi.org\/10.21931\/RB\/2023.08.04.33 (2023).","journal-title":"Revis. Bionatura"},{"key":"3506_CR10","doi-asserted-by":"publisher","unstructured":"Atef, D. M. & Atef, R. M. Usefulness of nucleic acid testing among negative HBs Ag blood donors in Egypt. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis, 58(4), 468\u2013471 (2019). https:\/\/doi.org\/10.1016\/j.transci.2019.05.005. Epub 2019 May 11. PMID: 31105059.","DOI":"10.1016\/j.transci.2019.05.005"},{"issue":"4","key":"3506_CR11","doi-asserted-by":"publisher","first-page":"e0267472","DOI":"10.1371\/journal.pone.0267472","volume":"17","author":"N Mabunda","year":"2022","unstructured":"Mabunda, N. et al. Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique. PLoS One. 17 (4), e0267472. https:\/\/doi.org\/10.1371\/journal.pone.0267472 (2022). PMID: 35482726; PMCID: PMC9049559.","journal-title":"PLoS One"},{"key":"3506_CR12","doi-asserted-by":"publisher","unstructured":"Ghosh, K. & Mishra, K. Nucleic acid amplification testing in Indian blood banks: A review with perspectives. Ind J Pathol Microbiol. 60(3): 313\u2013318 (2017). https:\/\/doi.org\/10.4103\/IJPM.IJPM_361_16. PMID: 28937364.","DOI":"10.4103\/IJPM.IJPM_361_16"},{"key":"3506_CR13","doi-asserted-by":"publisher","unstructured":"Velati, C. et al. &. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion, 48(10), 2205\u20132213 2008;48(10):2205-13. (2008). https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01813. x. Epub 2008 Jul 8. PMID: 18631163.","DOI":"10.1111\/j.1537-2995.2008.01813"},{"issue":"2","key":"3506_CR14","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.21608\/EJHM.2019.38887","volume":"76","author":"EY Ebeid","year":"2019","unstructured":"Ebeid, E. Y., Kholeif, H. A. E. & Hussein, N. H. Role of nucleic acid test (NAT) in detection of transfusion transmitted viruses in comparison to other methods. Egypt. J. Hosp. Med. 76 (2), 3542\u20133549. https:\/\/doi.org\/10.21608\/EJHM.2019.38887 (2019).","journal-title":"Egypt. J. Hosp. Med."},{"key":"3506_CR15","doi-asserted-by":"publisher","unstructured":"Mercaldo, N. D., Lau, K. F. & Zhou, X. H. Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. ;26(10):2170-83. (2007). https:\/\/doi.org\/10.1002\/sim.2677. PMID: 16927452.","DOI":"10.1002\/sim.2677"},{"key":"3506_CR16","unstructured":"MedCalc Software Ltd. Diagnostic test evaluation calculator. https:\/\/www.medcalc.org\/calc\/diagnostic_test.php (2025). Version 23.1.1; accessed January 2."},{"key":"3506_CR17","doi-asserted-by":"crossref","unstructured":"Attia, F. M., Farouk, A. M. & Abdelhady, S. A. Clinical significance of viral markers testing by ELISA and Individual Donation Nucleic Acid Testing (ID-NAT) for blood screening in blood bank: Single center study in Egypt. Egypt J Immunol. Apr;31(2):55\u201360 PMID: 38615235. (2024).","DOI":"10.55133\/eji.310206"},{"issue":"1","key":"3506_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21608\/scumj.2019.65380","volume":"22","author":"N Kamel","year":"2019","unstructured":"Kamel, N. & Rageh, F. Transfusion-Transmissible infections: Seroprevalence among donors in an Egyptian university blood bank. Suez Canal Univ. Med. J. 22 (1), 79\u201384 (2019).","journal-title":"Suez Canal Univ. Med. J."},{"issue":"4","key":"3506_CR19","doi-asserted-by":"publisher","first-page":"103965","DOI":"10.1016\/j.transci.2024.103965","volume":"63","author":"HA Sayed Ahmed","year":"2024","unstructured":"Sayed Ahmed, H. A., Kamel, N. & Mahfouz, E. M. Insight into hazards and control of transfusion-transmitted infections in Egypt: A narrative review. Transfus. Apher Sci. Aug. 63 (4), 103965. https:\/\/doi.org\/10.1016\/j.transci.2024.103965 (2024). Epub 2024 Jul 2. PMID: 38986352.","journal-title":"Transfus. Apher Sci. Aug"},{"key":"3506_CR20","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1111\/trf.16005","volume":"60","author":"WR Steele","year":"2020","unstructured":"Steele, W. R. et al. Prevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus in united States blood donations, 2015\u20132019: transfusion transmissible infections monitoring system (TTIMS). Transfusion 60, 2327\u20132339. https:\/\/doi.org\/10.1111\/trf.16005 (2020). Epub 2020 Aug 31. PMID: 32869326.","journal-title":"Transfusion"},{"key":"3506_CR21","doi-asserted-by":"publisher","unstructured":"Walana, W. et al. Transfusion transmissible infections among blood donors in Ghana: A 3-year multicentered health facility-based retrospective study. Health Sci Rep. Nov 1;6(11): e1681 (2023). https:\/\/doi.org\/10.1002\/hsr2.1681. PMID: 37927541; PMCID: PMC10620378.","DOI":"10.1002\/hsr2.1681"},{"issue":"1","key":"3506_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12879-018-3174-x","volume":"18","author":"N Siraj","year":"2018","unstructured":"Siraj, N. et al. Seroprevalence of transfusion-transmissible infections among blood donors at National blood transfusion service, Eritrea: a seven-year retrospective study. BMC Infect. Dis. 18 (1), 264. https:\/\/doi.org\/10.1186\/s12879-018-3174-x (2018). PMID: 29879912; PMCID: PMC5992706.","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"3506_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/bjh.18313","volume":"198","author":"AA Ogbenna","year":"2022","unstructured":"Ogbenna, A. A. et al. Reduction in Seroprevalence of viral transfusion-transmitted infections in Southwest Nigeria in children with sickle cell disease using an enhanced screening strategy. Br. J. Haematol. 198 (4), 745\u2013752. https:\/\/doi.org\/10.1111\/bjh.18313 (2022). Epub 2022 Jun 19. PMID: 35719004.","journal-title":"Br. J. Haematol."},{"issue":"3","key":"3506_CR24","doi-asserted-by":"publisher","first-page":"e0249061","DOI":"10.1371\/journal.pone.0249061","volume":"16","author":"A Mremi","year":"2021","unstructured":"Mremi, A., Yahaya, J. J., Nyindo, M. & Mollel, E. Transfusion-transmitted infections and associated risk factors at the Northern zone blood transfusion center in Tanzania: a study of blood donors between 2017 and 2019. PLoS ONE. 16 (3), e0249061 (2021).","journal-title":"PLoS ONE"},{"key":"3506_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-017-3088-5","volume":"11","author":"CG Onyango","year":"2018","unstructured":"Onyango, C. G. et al. Seroprevalence and determinants of transfusion transmissible infections among voluntary blood donors in Homabay, Kisumu and Siaya counties in Western Kenya. BMC Res. Notes. 11, 1\u20136 (2018).","journal-title":"BMC Res. Notes"},{"issue":"6","key":"3506_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/tme.13006","volume":"Dec;33","author":"E Singogo","year":"2023","unstructured":"Singogo, E. et al. Prevalence and incidence of transfusion-transmissible infections among blood donors in Malawi: A population-level study. Transfus. Med. Dec;33 (6), 483\u2013496. https:\/\/doi.org\/10.1111\/tme.13006 (2023). Epub 2023 Oct 12. PMID: 37828838; PMCID: PMC11096640.","journal-title":"Transfus. Med."},{"issue":"10","key":"3506_CR27","doi-asserted-by":"publisher","first-page":"e0241086","DOI":"10.1371\/journal.pone.0241086","volume":"15","author":"S Abdella","year":"2020","unstructured":"Abdella, S. et al. Sero-prevalence of transfusion transmittable infections: HIV, hepatitis B, C and Treponema pallidum and associated factors among blood donors in Ethiopia: a retrospective study. PLoS ONE. 15 (10), e0241086 (2020).","journal-title":"PLoS ONE"},{"issue":"5","key":"3506_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/tme.12988","volume":"33","author":"S Puerto-Meredith","year":"2023","unstructured":"Puerto-Meredith, S. et al. Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa. Transfus. Med. 33 (5), 355\u2013371. https:\/\/doi.org\/10.1111\/tme.12988 (2023). Epub 2023 Aug 28. PMID: 37641525; PMCID: PMC11070456.","journal-title":"Transfus. Med."},{"key":"3506_CR29","doi-asserted-by":"publisher","unstructured":"Jin-feng, C. H., Wei, J., Hong-xia, Z. & Virus, B. Application of Hepatitis Hepatitis C Virus and Human Immunodeficiency Virus Nucleic Acid Detection in Patients Undergoing Surgery. Journal of Clinical Transfusion and Laboratory Medicine, 22(6), 568\u2013573 (2020). https:\/\/doi.org\/10.3969\/j.issn.1671-2587.2020.06.003","DOI":"10.3969\/j.issn.1671-2587.2020.06.003"},{"key":"3506_CR30","doi-asserted-by":"crossref","unstructured":"Wasfi, O. Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. East Mediterr Health J, 17(3):238\u201342 PMID: 21735965. (2011).","DOI":"10.26719\/2011.17.3.238"},{"key":"3506_CR31","doi-asserted-by":"publisher","unstructured":"Stramer, S. L., Notari, E. P., Krysztof, D. E. & Dodd, R. Y. Hepatitis B virus testing by mini pool nucleic acid testing: does it improve blood safety? Transfusion. 53(10 Pt 2):2449\u20132458 https:\/\/doi.org\/10.1111\/trf.12213. (2013). Epub 2013 Apr 23. PMID: 23607261.","DOI":"10.1111\/trf.12213"},{"key":"3506_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/GJTM.GJTM_8_17","volume":"2","author":"A Mathur","year":"2017","unstructured":"Mathur, A., Dontula, S. & Jagannathan, L. A study of centralized individual donor nucleic acid testing for TTI to improve blood safety in Karnataka, India. Global J. TM. 2, 24\u201328. https:\/\/doi.org\/10.4103\/GJTM.GJTM_8_17 (2017).","journal-title":"Global J. TM"},{"key":"3506_CR33","doi-asserted-by":"publisher","unstructured":"Parkin, D. M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 118(12):3030\u20133044 (2006). https:\/\/doi.org\/10.1002\/ijc.21731. PMID: 16404738.","DOI":"10.1002\/ijc.21731"},{"issue":"2","key":"3506_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4254\/wjh.v5.i2.64","volume":"27","author":"ZN Said","year":"2013","unstructured":"Said, Z. N. et al. Occult hepatitis B virus infection among Egyptian blood donors. World J. Hepatol. Feb. 27 (2), 64\u201373. https:\/\/doi.org\/10.4254\/wjh.v5.i2.64 (2013). PMID: 23646231; PMCID: PMC3642725.","journal-title":"World J. Hepatol. Feb"},{"key":"3506_CR35","doi-asserted-by":"publisher","unstructured":"El-Ghitany, E. & Farghaly, A. Occult hepatitis B markers profile and significance in blood donors in Alexandria, Egypt. 15th ICID Abstracts \/. Int. J. Infect. Dis. 16S. e2\u2013e157. https:\/\/doi.org\/10.1016\/j.ijid.2012.05.189 (2012).","DOI":"10.1016\/j.ijid.2012.05.189"},{"key":"3506_CR36","doi-asserted-by":"publisher","unstructured":"Azzam, A., Khaled, H., El-Kayal, E. S., Gad, F. A. & Omar, S. Prevalence of occult hepatitis B virus infection in Egypt: a systematic review with meta-analysis. J Egypt Public Health Assoc. Jul 26;98(1):13 (2023). https:\/\/doi.org\/10.1186\/s42506-023-00138-4. PMID: 37491501; PMCID: PMC10368600.","DOI":"10.1186\/s42506-023-00138-4"},{"key":"3506_CR37","doi-asserted-by":"publisher","unstructured":"Senosy, S. A. Prevalence of HIV among blood donors at Beni-Suef University Hospital Blood Bank, Egypt. The Journal of the Egyptian Public Health Association, 90(4): 116\u2013157. 3 (2015). https:\/\/doi.org\/10.1097\/01.EPX.0000475668.57932.29. PMID: 26854896.","DOI":"10.1097\/01.EPX.0000475668.57932.29"},{"key":"3506_CR38","unstructured":"UNAIDS Country factsheets EGYPT. 2021. pp. 1\u20136. (2021). Available from: https:\/\/www.unaids.org\/en\/regionscountries\/countries\/egypt. cited 2024."},{"key":"3506_CR39","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s12889-023-15490-5","volume":"23","author":"RM Ghazy","year":"2023","unstructured":"Ghazy, R. M., Al Awaidy, S. & Taha, S. H. N. Trends of HIV indicators in Egypt from 1990 to 2021: time-series analysis and forecast toward UNAIDS 90-90-90 targets. BMC Public. Health. 23, 625. https:\/\/doi.org\/10.1186\/s12889-023-15490-5 (2023). PMID: 37005670; PMCID: PMC10066021.","journal-title":"BMC Public. Health"},{"key":"3506_CR40","unstructured":"UNICEF: Egypt Program HIV\/AIDS. (2016). Available from: https:\/\/www.unicef.org\/egypt\/hivaids#_ftn1. cited 2024."},{"key":"3506_CR41","unstructured":"United Nations Development Program. (2022). Available from: https:\/\/procurement-notices.undp.org\/view_notice.cfm?notice_id=96346. Cited 2024."},{"key":"3506_CR42","doi-asserted-by":"publisher","unstructured":"Ali, S. M. et al. Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, and HIV: A Tertiary Care Hospital Experience from Pakistan. Cureus. Jan 25;15(1): e34216 (2023). https:\/\/doi.org\/10.7759\/cureus.34216. PMID: 36852365; PMCID: PMC9958204.","DOI":"10.7759\/cureus.34216"},{"issue":"6","key":"3506_CR43","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/tme.12923","volume":"Dec;32","author":"HC Pandey","year":"2022","unstructured":"Pandey, H. C., Varghese, M., Rana, A., Kumar, R. & Jain, P. Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield\/window period model in an Indian setting. Transfus. Med. Dec;32 (6), 492\u2013498. https:\/\/doi.org\/10.1111\/tme.12923 (2022). Epub 2022 Oct 9. PMID: 36210486.","journal-title":"Transfus. Med."},{"key":"3506_CR44","doi-asserted-by":"publisher","unstructured":"Wu, D. et al. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review. BMC Infect Dis. Mar 23;22(1):279 (2022). https:\/\/doi.org\/10.1186\/s12879-022-07279-5. PMID: 35321684; PMCID: PMC8943971.","DOI":"10.1186\/s12879-022-07279-5"},{"key":"3506_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/vox.12770","volume":"114","author":"SA Fiedler","year":"2019","unstructured":"Fiedler, S. A. et al. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008\u20132015). Vox Sang. 114, 443\u2013450. https:\/\/doi.org\/10.1111\/vox.12770 (2019). Epub 2019 Apr 22. PMID: 31012114; PMCID: PMC6849742.","journal-title":"Vox Sang"},{"key":"3506_CR46","doi-asserted-by":"publisher","unstructured":"Fang, C. T., Field, S. P., Busch, M. P. & Heyns, A. P. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing. Vox Sang. 85:9\u201319 (2003). https:\/\/doi.org\/10.1046\/j.1423-0410.2003.00311. x. PMID: 12823725.","DOI":"10.1046\/j.1423-0410.2003.00311"},{"key":"3506_CR47","doi-asserted-by":"publisher","unstructured":"Dubravac, T., Gahan, T. F. & Pentella, M. A. Use of the Abbott Architect HIV antigen\/antibody assay in a low incidence population. J Clin Virol. 58 Suppl 1:e76-e78 (2013). https:\/\/doi.org\/10.1016\/j.jcv.2013.10.020. PMID: 24342481.","DOI":"10.1016\/j.jcv.2013.10.020"},{"key":"3506_CR48","unstructured":"Mansour, M. T. & Ismail, M. A. Evaluation of nucleic acid amplification testing technique (NAT) in blood banks. Egypt. J. Med. Microbiol. 15(1) (2006)."},{"key":"3506_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/1471-2334-13-288","volume":"24","author":"YA Mohamoud","year":"2013","unstructured":"Mohamoud, Y. A., Mumtaz, G. R., Riome, S., Miller, D. & Abu-Raddad, L. J. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect. Dis. Jun. 24, 13:288. https:\/\/doi.org\/10.1186\/1471-2334-13-288 (2013). PMID: 23799878; PMCID: PMC3702438.","journal-title":"BMC Infect. Dis. Jun"},{"issue":"6","key":"3506_CR50","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/trf.13061","volume":"55","author":"M El Ekiaby","year":"2015","unstructured":"El Ekiaby, M. et al. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios. Transfus. Jun. 55 (6), 1186\u20131194. https:\/\/doi.org\/10.1111\/trf.13061 (2015). Epub 2015 Mar 13. PMID: 25766141.","journal-title":"Transfus. Jun"},{"issue":"7","key":"3506_CR51","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.21608\/ejhm.2018.10167","volume":"72","author":"AM Ibrahim","year":"2018","unstructured":"Ibrahim, A. M. et al. Evaluation of some available HCV antibody detection tests (ELISA, chemiluminescence, immune Assay) and RT-PCR assay in the diagnosis of hepatitis C virus infection. Egypt. J. Hosp. Med. 72 (7), 4874\u20134879. https:\/\/doi.org\/10.21608\/ejhm.2018.10167 (2018).","journal-title":"Egypt. J. Hosp. Med."},{"key":"3506_CR52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000457965","volume":"44","author":"H Safic Stanic","year":"2017","unstructured":"Safic Stanic, H. et al. Three-year experience in NAT screening of blood donors for transfusion transmitted viruses in Croatia. Transfus. Med. Hemother. 44, 415\u2013420. https:\/\/doi.org\/10.1159\/000457965 (2017).","journal-title":"Transfus. Med. Hemother"},{"key":"3506_CR53","first-page":"257","volume":"81","author":"S Levicnik Stezinar","year":"2012","unstructured":"Levicnik Stezinar, S. & Nograsek, P. Yield of NAT screening in Slovenia. Zdrav Vestn. 81, 257\u2013264 (2012).","journal-title":"Zdrav Vestn"},{"issue":"1","key":"3506_CR54","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41598-017-17936-4","volume":"8","author":"SP Kouyoumjian","year":"2018","unstructured":"Kouyoumjian, S. P., Chemaitelly, H. & Abu-Raddad, L. J. Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions. Sci. Rep. 8 (1), 1661. https:\/\/doi.org\/10.1038\/s41598-017-17936-4 (2018). PMID: 29374178; PMCID: PMC5785953.","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03506-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T21:02:03Z","timestamp":1750798923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03506-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3506"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03506-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the local Ethical Committee: Institutional Research Board (IRB) of Mansoura Faculty of Medicine [R.23.12.2410], and all methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants from a parent and\/or legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"20109"}}